BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 1860266)

  • 1. Treatment of adult idiopathic nephrotic syndrome with cyclosporin A: minimal-change disease and focal-segmental glomerulosclerosis. Collaborative Group of the French Society of Nephrology.
    Meyrier A; Condamin MC; Broneer D
    Clin Nephrol; 1991; 35 Suppl 1():S37-42. PubMed ID: 1860266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The efficacy of cyclosporine A in adult nephrotic syndrome with minimal change disease and focal-segmental glomerulosclerosis: a multicenter study in Korea.
    Lee HY; Kim HS; Kang CM; Kim SG; Kim MJ
    Clin Nephrol; 1995 Jun; 43(6):375-81. PubMed ID: 7554521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and tolerability of cyclosporin A (Sandimmun) in idiopathic nephrotic syndrome. Collaborative Study Group of Sandimmun in Nephrotic Syndrome.
    Clin Nephrol; 1991; 35 Suppl 1():S48-60. PubMed ID: 1860268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term renal tolerance of cyclosporin A treatment in adult idiopathic nephrotic syndrome. Collaborative Group of the Société de Néphrologie.
    Meyrier A; Noël LH; Auriche P; Callard P
    Kidney Int; 1994 May; 45(5):1446-56. PubMed ID: 8072258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of corticoresistant idiopathic nephrotic syndrome in the adult: minimal change disease and focal segmental glomerulosclerosis.
    Meyrier A; Simon P
    Adv Nephrol Necker Hosp; 1988; 17():127-50. PubMed ID: 3124536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of idiopathic nephrotic syndrome with cyclosporin A in children.
    Niaudet P; Broyer M; Habib R
    Clin Nephrol; 1991; 35 Suppl 1():S31-6. PubMed ID: 1860265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minimal change disease and idiopathic focal segmental glomerulosclerosis in adults. A quantitative study.
    Danilewicz M; Wagrowska-Danilewicz M
    Pol J Pathol; 1996; 47(4):209-14. PubMed ID: 9097714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclosporine in idiopathic nephrotic syndrome.
    Ponticelli C
    Immunopharmacol Immunotoxicol; 1993 Aug; 15(4):479-89. PubMed ID: 8227973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclosporin A treatment in children with minimal change nephrotic syndrome and focal segmental glomerulosclerosis.
    Brodehl J; Brandis M; Helmchen U; Hoyer PF; Burghard R; Ehrich JH; Zimmerhackl RB; Klein W; Wonigeit K
    Klin Wochenschr; 1988 Nov; 66(22):1126-37. PubMed ID: 3236762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison between pre- and posttreatment renal biopsies in children receiving ciclosporine for idiopathic nephrosis.
    Habib R; Niaudet P
    Clin Nephrol; 1994 Sep; 42(3):141-6. PubMed ID: 7994931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclosporin in the treatment of steroid-responsive and steroid-resistant nephrotic syndrome in adults.
    Maher ER; Sweny P; Chappel M; Varghese Z; Moorhead JF
    Nephrol Dial Transplant; 1988; 3(6):728-32. PubMed ID: 3147413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term ciclosporine A treatment in adults with minimal change nephrotic syndrome or focal segmental glomerulosclerosis.
    Ittel TH; Clasen W; Fuhs M; Kindler J; Mihatsch MJ; Sieberth HG
    Clin Nephrol; 1995 Sep; 44(3):156-62. PubMed ID: 8556831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rituximab in minimal change nephropathy and focal segmental glomerulosclerosis: report of four cases and review of the literature.
    Peters HP; van de Kar NC; Wetzels JF
    Neth J Med; 2008 Nov; 66(10):408-15. PubMed ID: 19011266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and morphological prognostic factors in membranous nephropathy: significance of focal segmental glomerulosclerosis.
    Dumoulin A; Hill GS; Montseny JJ; Meyrier A
    Am J Kidney Dis; 2003 Jan; 41(1):38-48. PubMed ID: 12500220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary cytokines and steroid responsiveness in idiopathic nephrotic syndrome of childhood.
    Woroniecki RP; Shatat IF; Supe K; Du Z; Kaskel FJ
    Am J Nephrol; 2008; 28(1):83-90. PubMed ID: 17914249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience.
    El-Husseini A; El-Basuony F; Mahmoud I; Sheashaa H; Sabry A; Hassan R; Taha N; Hassan N; Sayed-Ahmad N; Sobh M
    Nephrol Dial Transplant; 2005 Nov; 20(11):2433-8. PubMed ID: 16204303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Steroid-resistant idiopathic childhood nephrosis: overdiagnosed and undertreated.
    Ehrich JH; Geerlings C; Zivicnjak M; Franke D; Geerlings H; Gellermann J
    Nephrol Dial Transplant; 2007 Aug; 22(8):2183-93. PubMed ID: 17504846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclosporin therapy for steroid resistant nephrotic focal glomerulosclerosis.
    Windom HH; Fisher M; Neale TJ
    N Z Med J; 1990 Mar; 103(886):125-6. PubMed ID: 2320338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-centre experience with cyclosporin in 106 children with idiopathic focal segmental glomerulosclerosis.
    Mahmoud I; Basuni F; Sabry A; El-Husseini A; Hassan N; Ahmad NS; Elbaz M; Moustafa F; Sobh M
    Nephrol Dial Transplant; 2005 Apr; 20(4):735-42. PubMed ID: 15772265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of prolonged immunosuppression on the outcome of idiopathic focal-segmental glomerulosclerosis with nephrotic syndrome in adults. A collaborative retrospective study.
    Banfi G; Moriggi M; Sabadini E; Fellin G; D'Amico G; Ponticelli C
    Clin Nephrol; 1991 Aug; 36(2):53-9. PubMed ID: 1934660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.